Category: press statement – en

Meet Eternygen at BioEurope conference in Leipzig from 23-26 October 2022.

Dr. Grit Zahn, Head of Research of Eternygen GmbH will present at the biotx.ai webinar on 29th September 2022. Link

Dr. Grit Zahn, Head of Research of Eternygen GmbH will be speaking at TESS Research Foundation's International Research Conference in [...]

Eternygen Announces the First Closing of its Series A2 Funding Round

News of Eternygen

Eternygen is presenting at „BioLaunchPad, the company showcase platform of BioTrinity” from 28 April – 1 May 2020. Link

Dr. Grit Zahn, Head of Research of Eternygen GmbH presents at the 4th International SLC13A5 Deficiency Research Roundtable of the […]

Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH Press statement

Meet Eternygen at the Biotech Showcase conference 2020 in San Francisco, CA, USA Eternygen is attending the Biotech Showcase conference […]

Meet Eternygen at BioEurope conference in Hamburg from November 11th to 13th Eternygen will attend the BioEurope conference in Hamburg […]

Prof. Birkenfeld was appointed as Chair of Medicine and Director of the Department of Diabetology, Endocrinology and Nephrology at the […]

Prof. Birkenfeld was awarded with the Abstract Award Prof. Birkenfeld was awarded with the Abstract Award by the American College […]

Eternygen at BioFIT 2017 Eternygen was invited to join panel discussion at BioFIT 2017 conference “How are collaborations key to […]

Prof. Birkenfeld is chairman of the working group diabetes and heart Prof. Birkenfeld is the new chairman of the working […]

Eternygen GmbH is part of the Network for Pharma Solutions (NetPhaSol, Germany) Press release

Eternygen GmbH closes € 8.0 (US$ 8.3) million Series A financing Eternygen GmbH Closes € 8.0 (US$ 8.3) million Series […]

Prof. Jordan takes on position as Head of the Institute of Aerospace Medicine “Prof. Jordan takes on position as Head […]

TransCampus Network between TU Dresden and King’s College London receives €5million grant The TransCampus network between King’s and Technische Universität […]

Eteryngen at 7th International IQPC Conference Eternygen GmbH today announced that its head of research will present at the 7th International […]

Prof. Birkenfeld to take over the succession of Prof. Markolf Hanefeld at centre of clinical studies in Dresden Interview by […]

Prof. Jordan receives renowned Peter Sleight Award Prof. Jordan receives renowned Peter Sleight Award of the european society of Hypertension […]

Prof. Birkenfeld to receive renowned Ferdinand Bertram price Press statement of GWT (in German) Article in Sächsische Zeitung (in German)

BioEquity Europe Conference Eternygen GmbH will present a corporate overview of the company at the 16 th BioEquity Europe Conference, […]

Creation of a Transcampus between TU Dresden and King’s College London PubMed Article Introduction of Transcampus Initiative by King’s College […]

Prof. Birkenfeld transfers to TU Dresden Press statement GWT (in German) 

Evotec and Eternygen Cooperation Evotec and Eternygen enter collaboration to identify and develop novel metabolic disease therapy. download press statement

Dr. Grit Zahn new head of research Eternygen appoints Dr. Grit Zahn as Head of Research. download press statement

Eternygen GmbH receives funding Eternygen GmbH receives funding from IBB Beteiligungsgesellschaft. download press statement